The recombinant TLR-MD-2 fusion protein or a fusion protein homopolymer / heteropolymer complex can be used for the prophylactic and/or therapeutic treatment…
The novel conjugate molecules are provided for the manufacture of a medicament for gene therapy, apoptosis, or for the treatment of diseases such as cancer,…
The invention relates to a pharmaceutical composition comprising an inhibitor of SLY-1 (SH3 domain protein expressed in lymphocytes).Further Information: PDF Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V….
The invention consists of a new system for the expression of proteins in E. coli and its applications.
Compared to the state of the art the new autodisplay…
This invention covers a new process that allows the stabilization and activation of sensitive catalysts (respectively enzymes) to be used in organic…
The invention concerns a market ready and provable technical process for the “super activation” of polysaccharides (e.g. cellulose, starch, chitin) for the…